Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild-to-moderate COVID-19”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT05124210
What this trial is testing

Pharmacokinetics, Pharmacodynamics, and Safety of Single-dose Sotrovimab in High-risk Pediatric Participants With Mild to Moderate COVID-19

Who this might be right for
COVID-19
GlaxoSmithKline 8
Testing effectiveness (Phase 2)Study completedNCT05676073
What this trial is testing

Study of SHEN26 Capsule in Patients With Mild to Moderate COVID-19

Who this might be right for
COVID-19
Shenzhen Kexing Pharmaceutical Co., Ltd. 91
Testing effectiveness (Phase 2)Study completedNCT04399356
What this trial is testing

Niclosamide for Mild to Moderate COVID-19

Who this might be right for
COVID-19
Tufts Medical Center 73
Large-scale testing (Phase 3)Study completedNCT05716425
What this trial is testing

Study to Assess the Efficacy and Safety of STI-1558 in Adult Subjects With Mild or Moderate (COVID-19)

Who this might be right for
COVID-19
Zhejiang ACEA Pharmaceutical Co. Ltd. 1,218
Testing effectiveness (Phase 2)Study completedNCT05076253
What this trial is testing

Efficacy of Ivermectin in COVID-19

Who this might be right for
SafetySARS-CoV2 InfectionIvermectin Poisoning+1 more
Bangkok Metropolitan Administration Medical College and Vajira Hospital 72
Testing effectiveness (Phase 2)Temporarily pausedNCT04711863
What this trial is testing

Fluvoxamine for Adults With Mild to Moderate COVID-19

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2Coronavirus InfectionMild to Moderate COVID-19
Asan Medical Center 400
Testing effectiveness (Phase 2)Study completedNCT05941793
What this trial is testing

Evaluate the Efficacy, Safety, and Concentration of SNS812 in Mild to Moderate COVID-19 Patients

Who this might be right for
Mild to Moderate COVID-19
Oneness Biotech Co., Ltd. 135
Not applicableStudy completedNCT04512027
What this trial is testing

Prolectin-M in COVID-19 Patients Having Mild to Moderate Symptoms Not Requiring Oxygen Support.

Who this might be right for
COVID-19
Composite Interceptive Med Science 10
Testing effectiveness (Phase 2)UnknownNCT05689203
What this trial is testing

Evaluate the Efficacy and Safety of QLS1128 Orally in Symptomatic Participants With Mild to Moderate COVID-19

Who this might be right for
COVID-19
Qilu Pharmaceutical Co., Ltd. 360
Not applicableUnknownNCT06223932
What this trial is testing

Evaluation of the Efficacy and Safety of Molnupiravir Treatment in Mild/Moderate Covid-19 Patients.

Who this might be right for
COVID-19SARS-CoV-2 Infection
Serap Yavuz 2,600
Testing effectiveness (Phase 2)Study completedNCT05092503
What this trial is testing

JINZHEN for Treatment of Mild to Moderate COVID-19

Who this might be right for
COVID-19
Lianyungang Kanion Group, Ltd. 60
Testing effectiveness (Phase 2)Study completedNCT05069610
What this trial is testing

Evaluating Safety, Tolerability, and Potential Efficacy of Intranasal AD17002 in Adults With Mild to Moderate COVID-19

Who this might be right for
COVID-19
Advagene Biopharma Co. Ltd. 30
Testing effectiveness (Phase 2)Study completedNCT04523181
What this trial is testing

Double-blind Study to Evaluate the Safety and Efficacy of Antroquinonol in Mild-Moderate COVID-19 Hospitalized Patients

Who this might be right for
Covid-19
Golden Biotechnology Corporation 124
Not applicableUnknownNCT04429711
What this trial is testing

Ivermectin vs. Placebo for the Treatment of Patients With Mild to Moderate COVID-19

Who this might be right for
COVID-19
Sheba Medical Center 100
Large-scale testing (Phase 3)UnknownNCT05908071
What this trial is testing

Study Evaluating SHEN26 Capsule in Patients With Mild to Moderate COVID-19

Who this might be right for
COVID-19
Shenzhen Kexing Pharmaceutical Co., Ltd. 1,200
Testing effectiveness (Phase 2)Study completedNCT04701658
What this trial is testing

A Real World Study of Bamlanivimab in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)

Who this might be right for
COVID-19
Eli Lilly and Company 109
Testing effectiveness (Phase 2)Study completedNCT04533347
What this trial is testing

Tafenoquine in Patients With Mild to Moderate COVID-19

Who this might be right for
COVID 19 Disease
60 Degrees Pharmaceuticals LLC 86
Testing effectiveness (Phase 2)UnknownNCT04627584
What this trial is testing

Clinical Trial of MW33 Injection in Patients With COVID-19

Who this might be right for
Covid19
Mabwell (Shanghai) Bioscience Co., Ltd. 150
Large-scale testing (Phase 3)WithdrawnNCT05552625
What this trial is testing

The Efficacy and Safety of TADIOS as an Adjuvant Therapy in Patients Diagnosed With Mild to Moderate COVID-19

Who this might be right for
COVID-19
Helixmith Co., Ltd.
Not applicableStudy completedNCT04716647
What this trial is testing

Feasibility of Ayurveda in Patients With Mild-to-Moderate COVID-19: A Community-Based Participatory Research

Who this might be right for
Covid19
Aarogyam UK 28
Next Page